P. Carli

发表

Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

P. Ravaud, X. Mariette, L. Chiche, 2012, Annals of the rheumatic diseases.

Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.

C. Ribi, X. Kyndt, X. Puéchal, 2010, Arthritis and rheumatism.

Early care and treatment with a neuroprotective drug, gacyclidine, in patients with acute spinal cord injury

A. Privat, C. Saint-Marc, M. Tadié, 2003 .

COVID-19 experience: first Italian survey on healthcare staff members from a Mother-Child Research hospital using combined molecular and rapid immunoassays test

A. Morgan, M. Brumat, P. Gasparini, 2020, medRxiv.

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry

M. Dougados, P. Ravaud, E. Andrès, 2015, RMD Open.

Toxicodynetics: A new discipline in clinical toxicology.

P. Carli, F. Baud, S. Borron, 2016, Annales pharmaceutiques francaises.

The Spectrum of Renal Involvement in Patients With Inflammatory Myopathies

E. Hachulla, M. Laville, P. Rémy, 2014, Medicine.

[Right ventricular failure as the presenting manifestation of a carcinoid syndrome].

P. Carli, M. Aletti, C. Jégo, 2009, La Revue de medecine interne.

AB0233 Diagnosis and Evolution of Anti-Citrullinated Peptide Antibody (ACPA)-Negative Rheumatoid Arthritis (RA) Patients: A Retrospective Study of 48 Patients

N. Balandraud, J. Roudier, P. Carli, 2014 .

[Respiratory manifestations of giant cell arteritis: 8 cases and review of the literature].

G. Cinquetti, P. Carli, F. Banal, 2010, Presse medicale.